Table of Contents
Journal of Blood Transfusion
Volume 2015, Article ID 720389, 5 pages
http://dx.doi.org/10.1155/2015/720389
Research Article

Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa

1Centre National de Transfusion Sanguine (CNTS), Libreville, Gabon
2Service d’Anesthésie-Réanimation du Centre Hospitalier Universitaire de Libreville, Libreville, Gabon
3Centre National d’Hémodialyse de Libreville, Libreville, Gabon
4Centre Hospitalier Universitaire d’Angondjè, Libreville, Gabon
5Unité de Recherche et de Diagnostic Spécialisé/Laboratoire National de Santé Publique (URDS/LNSP), Libreville, Gabon

Received 13 October 2014; Revised 8 December 2014; Accepted 11 December 2014

Academic Editor: Rajendra Chaudhary

Copyright © 2015 Leonard Kouegnigan Rerambiah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Urrechaga, L. Borque, and J. F. Escanero, “Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability,” International Journal of Laboratory Hematology, vol. 35, no. 2, pp. 144–149, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. L. T. Goodnough, E. Nemeth, and T. Ganz, “Detection, evaluation, and management of iron-restricted erythropoiesis,” Blood, vol. 116, no. 23, pp. 4754–4761, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. E. Lankhorst and J. B. Wish, “Anemia in renal disease: diagnosis and management,” Blood Reviews, vol. 24, no. 1, pp. 39–47, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. V. Ramanath, D. Gupta, J. Jain, K. Chaudhary, and R. Nistala, “Anemia and chronic kidney disease: making sense of the recent trials,” Reviews on Recent Clinical Trials, vol. 7, no. 3, pp. 187–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Kapoian, “Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron,” The American Journal of Kidney Diseases, vol. 52, pp. S21–S28, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. W. H. Hörl, Y. Vanrenterghem, B. Canaud et al., “Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin,” Nephrology Dialysis Transplantation, vol. 20, supplement 3, pp. iii25–iii32, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. Van Buren, R. L. Velez, N. D. Vaziri, and X. J. Zhou, “Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD,” International Urology and Nephrology, vol. 44, no. 2, pp. 499–507, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. H. Ghoti, E. A. Rachmilewitz, R. Simon-Lopez et al., “Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron,” European Journal of Haematology, vol. 89, no. 1, pp. 87–93, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. K. S. Gill, P. Muntner, R. A. Lafayette et al., “Red blood cell transfusion use in patients with chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 28, no. 6, pp. 1504–1515, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. W. H. Dzik, H. Corwin, L. T. Goodnough et al., “Patient safety and blood transfusion: new solutions,” Transfusion Medicine Reviews, vol. 17, no. 3, pp. 169–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. L. T. Goodnough, “Risks of blood transfusion,” Critical Care Medicine, vol. 31, no. 12, pp. S678–S686, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. T. Goodnough, A. Shander, and M. E. Brecher, “Transfusion medicine: looking to the future,” The Lancet, vol. 361, no. 9352, pp. 161–169, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. Y. C. Tanhehco and J. S. Berns, “Red blood cell transfusion risks in patients with end-stage renal disease,” Seminars in Dialysis, vol. 25, no. 5, pp. 539–544, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. L. K. Rerambiah, L. E. Rerambiah, C. Bengone, and J. F. Djoba Siawaya, “The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre,” Blood Transfusion, vol. 12, no. 3, pp. 330–333, 2014. View at Google Scholar
  15. C. T. Tagny, E. L. Murphy, and J.-J. Lefrère, “The Francophone Africa blood transfusion research network: a five-year report (2007–2012),” Transfusion Medicine, vol. 23, no. 6, pp. 442–444, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. Baby, S. Fongoro, M. Cissé et al., “Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of Point G, Bamako, Mali,” Transfusion Clinique et Biologique, vol. 17, no. 4, pp. 218–222, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. S. Shukla and R. K. Chaudhary, “Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis,” Indian Journal of Pathology and Microbiology, vol. 42, no. 3, pp. 299–302, 1999. View at Google Scholar · View at Scopus
  18. R. M. Hakim, J. C. Stivelman, G. Schulman et al., “Iron overload and mobilization in long-term hemodialysis patients,” American Journal of Kidney Diseases, vol. 10, no. 4, pp. 293–299, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. J. B. Wish, “Assessing iron status: beyond serum ferritin and transferrin saturation,” Clinical Journal of the American Society of Nephrology, vol. 1, supplement 1, pp. S4–S8, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Kalantar-Zadeh and G. H. Lee, “The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?” Clinical Journal of the American Society of Nephrology, vol. 1, supplement 1, pp. S9–S18, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Kalantar-Zadeh, F. C. Luft, M. H. Humphreys, J. W. Eschbach, and J. W. Adamson, “Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients,” Kidney International, vol. 56, no. 2, pp. 758–759, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. A. V. Hoffbrand, A. Taher, and M. D. Cappellini, “How I treat transfusional iron overload,” Blood, vol. 120, no. 18, pp. 3657–3669, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. T. G. St. Pierre, P. R. Clark, and W. Chua-Anusorn, “Measurement and mapping of liver iron concentrations using magnetic resonance imaging,” Annals of the New York Academy of Sciences, vol. 1054, pp. 379–385, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. G. St. Pierre, P. R. Clark, W. Chua-Anusorn et al., “Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance,” Blood, vol. 105, no. 2, pp. 855–861, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. T. G. St. Pierre, A. El-Beshlawy, M. Elalfy et al., “Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration,” Magnetic Resonance in Medicine, vol. 71, no. 6, pp. 2215–2223, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus